CEO Jung Jong-seon increases stake in SyntekaBio to 14.61% via open market purchase of 60,000 shares

CEO Jung Jong-seon purchased 60,000 common shares of SyntekaBio on June 25 and 26, 2026 at an average price of 1,562 KRW per share via open market transactions.
As a result, his total holdings increased to 3,543,710 shares, raising his ownership from 14.36% to 14.61% of total outstanding shares.
This insider buying by the largest shareholder and CEO signals confidence in the company's value, potentially serving as a positive market signal.
[AI Summary]The voluntary stake increase by the top executive demonstrates management commitment without financial leverage, and may provide downside support. However, the modest increment limits near-term price impact.